Research Article
[Retracted] Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer
Table 2
Comprehensive treatment of patients with different stages of cervical cancer.
| Item | FIGO stage | I | II | III/IV |
| Case | 34 | 43 | 30 | Surgery (%) | 97.06% | 51.16% | 33.33% | Frequency of RIC (%) | 35.29% | 39.53% | 13.33% | Prescription dose (Gy) | 50.06 | 55.20 | 59.49 | Single dose (Gy) | 2.00 | 2.19 | 2.30 | Volume of CTV (cm3) | 384.82 | 483.58 | 585.56 | Volume of bladder (cm3) | 325.56 | 310.56 | 315.70 | Volume of bladder wall (cm3) | 44.25 | 42.69 | 44.02 | Dmax (Gy) | 54.52 | 59.16 | 63.99 | Dmean (Gy) | 41.03 | 42.05 | 44.02 |
|
|
Average value. RIC: radiation-induced cystitis; CTV: clinical tumor volume; Dmax: the maximal dose; D mean: the mean dose. |